WHSC2 anticorps (AA 280-511)

N° du produit ABIN1846367

Détail du produit anti-WHSC2 anticorps

Antigène: WHSC2 (Wolf-Hirschhorn Syndrome Candidate 2 (WHSC2))

Épitope: AA 280-511

Reactivité: Humain, Rat

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp WHSC2 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunofluorescence (fixed cells) (IF/ICC)

Purification: Purified antibody

Immunogène: Purified recombinant fragment of human WHSC2 (AA: 280-511) expressed in E. coli.

Isotype: IgG2b

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1.0 mg/mL

Buffer: PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.

Détails sur WHSC2

Antigène: WHSC2 (Wolf-Hirschhorn Syndrome Candidate 2 (WHSC2))

Autre désignation: WHSC2 (WHSC2 Produits)

Synonymes: anticorps BcDNA:SD07139, anticorps CG5874, anticorps Dmel\\CG5874, anticorps NELF, anticorps NELF-A, anticorps Whsc2, anticorps fi75f03, anticorps whsc2, anticorps wu:fi75f03, anticorps MGC85474, anticorps WHSC2, anticorps nelfa, anticorps nelf-a, anticorps p/okcl.15, anticorps Whsc2h, anticorps Negative elongation factor A, anticorps negative elongation factor complex member A, anticorps negative elongation factor complex member A L homeolog, anticorps negative elongation factor complex member A, Whsc2, anticorps Nelf-A, anticorps Nelfa, anticorps nelfa, anticorps nelfa.L, anticorps NELFA

Sujet: This gene is expressed ubiquitously with higher levels in fetal than in adult tissues.It encodes a protein sharing 93% sequence identity with the mouse protein.Wolf-Hirschhorn syndrome (WHS) is a malformation syndrome associated with a hemizygous deletion of the distal short arm of chromosome 4.This gene is mapped to the 165 kb WHS critical region, and may play a role in the phenotype of the WHS or Pitt-Rogers-Danks syndrome.The encoded protein is found to be capable of reacting with HLA-A2-restricted and tumor-specific cytotoxic T lymphocytes, suggesting a target for use in specific immunotherapy for a large number of cancer patients.This protein has also been shown to be a member of the NELF (negative elongation factor) protein complex that participates in the regulation of RNA polymerase II transcription elongation.

Poids moléculaire: 57.3 kDa

ID gène: 7469

Pathways: Chromatin Binding